Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach

Home > Science Hub > Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach
Back to the list

November 4, 2018

Simon Bourque, Sharon Y.T. Lin, Daniela Vasilescu, Rudolf Guilbaud, Michael Schirm and Lorella Di Donato

Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach, AAPS 2018

Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach

Download poster

You might also be interested by

Brochures

Immuno-MRM Assays

August 4, 2023

Proteomics/Mass Spectrometry

More info

Webinars

Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions

May 2, 2023

Proteomics/Mass Spectrometry

More info

Posters

Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC

April 17, 2023

Proteomics/Mass Spectrometry

More info

Brochures

Empower Cancer Research with Proteomics

April 11, 2023

Proteomics/Mass Spectrometry

More info